129 Aufrufe 129 0 Kommentare 0 Kommentare

    CBD Life Sciences Inc. (CBDL) Reports 1,502.30% Revenue Increase from January to May 2025

    Achieving a five-month revenue growth equivalent to an annualized rate exceeding 4,000%, as the booming CBD and mushroom supplement markets-projected to reach $30 billion and $15 billion respectively by 2028-fuel strong consumer demand and industry …

    Achieving a five-month revenue growth equivalent to an annualized rate exceeding 4,000%, as the booming CBD and mushroom supplement markets-projected to reach $30 billion and $15 billion respectively by 2028-fuel strong consumer demand and industry expansion.

    SCOTTSDALE, AZ / ACCESS Newswire / June 11, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a rising player in the natural health and wellness space, is proud to report a 1,502.30% increase in revenue from January through May of 2025 - a historic milestone for the company and a clear reflection of its expanding presence across retail, digital, and direct-to-consumer channels.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Shopify Inc.!
    Short
    135,52€
    Basispreis
    0,76
    Ask
    × 14,38
    Hebel
    Zum Produkt
    Blatt
    Long
    119,28€
    Basispreis
    0,76
    Ask
    × 14,38
    Hebel
    Zum Produkt
    Blatt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    This performance marks the company's strongest run of sustained month-over-month revenue growth to date and comes as CBDL shifts from a single-category CBD company to a diversified wellness brand with products designed for modern performance, recovery, and cognitive support.

    "This isn't just about selling more products - it's about becoming a health brand that consumers actively seek out," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We've laid the foundation for scalable, repeatable success by combining innovation, access, and a strong identity in functional wellness."

    Key Drivers Of Growth

    National Retail Expansion & E-Commerce Ubiquity
    CBDL's ability to meet consumers where they shop has been a major growth catalyst in 2025. The brand has successfully launched and scaled across high-traffic digital and physical platforms, including:

    • Walmart Marketplace: Multiple SKUs now available online, including CBDL's best-selling 3000MG Pain Relief Cream and skin care formulations.

    • DoorDash & Leafly: Products are accessible via local delivery in select markets, offering speed and convenience for customers.

    • Groupon: Strategic limited-time wellness deals driving strong first-time purchase activity and consumer discovery.

    • Shopify & Reddit: Expanded direct-to-consumer operations through Shopify, complemented by engagement in Reddit's niche wellness communities to boost brand awareness and customer acquisition.

    Product Innovation: Functional Wellness for the Modern Consumer

    CBDL's revenue growth closely aligns with its rapid innovation across plant-powered health categories. Beyond CBD, the company is gaining traction with functional and adaptogenic wellness products, including:

    • Mushroom Smoothies & Brain Support Blends: Featuring natural cognitive enhancers like lion's mane, reishi, and cordyceps, these smoothies support memory, mental clarity, and energy - and are appearing in local coffee shops and health stores.

    Seite 1 von 2 




    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We are ACCESS Newswire, a globally trusted Public Relations (PR) and Investor Relations (IR) solutions provider. With a focus on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands to connect with their audiences where it matters most. From startups and scale-ups to multi-billion-dollar global brands, we ensure your most important moments make an impact and resonate with your audiences.
    Mehr anzeigen

    Verfasst von Accesswire
    CBD Life Sciences Inc. (CBDL) Reports 1,502.30% Revenue Increase from January to May 2025 Achieving a five-month revenue growth equivalent to an annualized rate exceeding 4,000%, as the booming CBD and mushroom supplement markets-projected to reach $30 billion and $15 billion respectively by 2028-fuel strong consumer demand and industry …